Clarendon Private LLC Sells 1,719 Shares of Procter & Gamble Company (The) $PG

Clarendon Private LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 46.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,957 shares of the company’s stock after selling 1,719 shares during the quarter. Clarendon Private LLC’s holdings in Procter & Gamble were worth $312,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of PG. Nova Wealth Management Inc. bought a new position in shares of Procter & Gamble during the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC boosted its holdings in Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after acquiring an additional 72 shares during the period. Quarry LP purchased a new stake in Procter & Gamble during the 1st quarter valued at about $33,000. Mizuho Securities Co. Ltd. boosted its holdings in Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 170 shares during the period. Finally, RMG Wealth Management LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at about $37,000. 65.77% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the transaction, the insider owned 182,422 shares in the company, valued at $28,689,507.94. This trade represents a 5.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares of the company’s stock, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 over the last quarter. Company insiders own 0.20% of the company’s stock.

Procter & Gamble Trading Down 0.6%

NYSE PG opened at $149.69 on Monday. Procter & Gamble Company has a fifty-two week low of $149.45 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a 50 day simple moving average of $155.24 and a two-hundred day simple moving average of $159.41. The stock has a market cap of $350.34 billion, a P/E ratio of 22.99, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last released its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Evercore ISI restated an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. BNP Paribas Exane dropped their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Finally, Barclays dropped their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $172.21.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.